Emily Leproust co-founded and leads Twist Bioscience and serves on NFX’s Bio Investment Committee. Before Twist, she developed DNA synthesis technologies and commercial products at Agilent Technologies, following research on parallel DNA and RNA synthesis at the University of Houston.
Emily Leproust co-founded and leads Twist Bioscience and serves on NFX’s Bio Investment Committee. Before Twist, she developed DNA synthesis technologies and commercial products at Agilent Technologies, following research on parallel DNA and RNA synthesis at the University of Houston.
Career
TBCo-Founder and CEO at Twist Bioscience until Present
Bio Investment Committee at NFX until Present